Flubromazolam’s role in scientific trials is restricted due to its classification as being a designer drug. However, its consequences have been reversed with the benzodiazepine antagonist flumazenil in pharmacokinetic scientific studies, giving insights into its medical implications and emergency administration of overdoses.As on the list of UK�